Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Change in Directorate

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · · 3 pages · English

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-change-in-directorate-329

Release

We inform you that at the meeting of Board of Directors of the Company on 6th March, 2025 the Board has, on the recommendation of the Nomination and Remuneration Committee, with Consent of Mr. Manoj Lodha, appointed Mr. Manoj Lodha as an Executive Director and Chief Financial Officer of the Company w.e.f. 1st April, 2025.

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases